Europe Bispecific Antibodies Market Size & Outlook, 2025-2031
Europe Bispecific Antibodies Market Size
According to Straits Research analysis, The Europe Bispecific Antibodies Market was valued at USD 1476.71 Million in 2024 and is projected to reach USD 3736.11 Million by 2031, expanding at a CAGR of 15% during the forecast period. This market boom is primarily driven by the high prevalence of diseases such as cancer and various infectious ailments. Moreover, expanding research and development actions, advancements in genetic sequencing, and protein engineering techniques further fuel market growth. Emerging opportunities like green production methods and sustainability in bispecific antibodies manufacturing are now trends in the European market. With robust technological advancements and a strong export potential, Europe is strategically poised to dominate the bispecific antibodies market, acting as a spearhead for innovations in the biotech industry.
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Bispecific Antibodies Market Highlights
- In 2024, Bi-specific T-cell engager emerged as the dominant Type based on market size.
- Bi-specific T-cell engager is projected to register the fastest growth, positioning it as the most attractive Type segment over the forecast horizon.
- In 2024, Europe contributed 26.79% to the overall global bispecific antibodies market size.
- By 2031, United States is anticipated to dominate the global market based on market size.
- Germany is expected to witness the fastest growth within Europe, attaining USD 398.46 Million by 2031.
- 📊 Preview Report Scope and Structure – Gain immediate visibility into key topics, market segments, and data frameworks covered.
- 📥 Evaluate Strategic Insights – Access selected charts, statistics, and analyst-driven commentary derived from the final report deliverables.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2031 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2031 |
| Market Size In 2024 | USD 1476.71 Million |
| Market Size In 2031 | USD 3736.11 Million |
| Largest segment | Bi-specific T-cell engager |
| Fastest segment | Bi-specific T-cell engager |
| Units | Revenue in USD Million |
| CAGR | 15% (2025-2031) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Europe Bispecific Antibodies Market Share By Type
Segmentation Covered
| Segments | Sub Segments |
|---|---|
| Country |
|
| Type |
|
| Therapeutic Areas |
|
| Target |
|
Europe Bispecific Antibodies Market By Country 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Bispecific Antibodies Market By Type 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Bispecific Antibodies Market By Therapeutic Areas 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
Europe Bispecific Antibodies Market By Target 2031
Source: Straits Research Analysis Company Publications, Primary Interviews.
